Quarterly report pursuant to Section 13 or 15(d)

EARNINGS (LOSS) PER SHARE -Schedule of Earnings Income (Loss) Per Share (Details)

v3.24.3
EARNINGS (LOSS) PER SHARE -Schedule of Earnings Income (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Net income $ (13,967) $ (26,212) $ 52,035 $ 608,444 $ 93,687 $ 523,054 $ 11,856 $ 1,225,185
Dividends on preferred stock (1,093)     (1,133)     (3,293) (3,718)
Participating securities - preferred stock 0     (89,756)     (1,259) (180,394)
Net income attributable to common stockholders (15,060)     517,555     7,304 1,041,073
Re-allocation of participating securities 0     1,147     20 2,043
Diluted net income (loss) attributable to common stockholders $ (15,060)     $ 518,702     $ 7,324 $ 1,043,116
Basic shares (in shares) 18,062     18,670     18,133 18,686
Dilutive shares (in shares) 18,062     18,954     18,463 18,937
Basic EPS (in usd per share) $ (0.83)     $ 27.72     $ 0.40 $ 55.72
Dilutive EPS (in usd per share) $ (0.83)     $ 27.37     $ 0.40 $ 55.08
Restricted Stock                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Dilutive shares (in shares) 200     300     300 300
Series A Convertible Preferred Stock                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Anti-dilutive shares (in shares) 3,100     3,200     3,100 3,200